Effects of the 3-hydroxyanthranilic acid analogue NCR-631 on anoxia-, IL-1β- and LPS-induced hippocampal pyramidal cell loss in vitro

Amino Acids

Volumn 14, Issue 1-3, 1998, Pages 263-269

  Luthman, J ^a   Radesater A C ^a   Oberg C ^a  

^a Astra Arcus AB ^*  (Sweden)

Author keywords

3 Hydroxyanthranilic acid; Anoxia; Interleukin 1; Kynurenine pathway; Neurodegeneration; Neuroinflammation

Indexed keywords

3 HYDROXYANTHRANILATE 3,4 DIOXYGENASE; 3 HYDROXYANTHRANILIC ACID; ENZYME INHIBITOR; INTERLEUKIN 1BETA; KYNURENINE; LIPOPOLYSACCHARIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NCR 631; NEUROPROTECTIVE AGENT; NITROGEN; QUINOLINIC ACID; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANOXIA; CELL LOSS; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; NEUROPATHOLOGY; NEUROPROTECTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT;

3-HYDROXYANTHRANILIC ACID; ANIMALS; ANOREXIA; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; N-METHYLASPARTATE; ORGAN CULTURE TECHNIQUES; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; HIPPOCAMPUS HIPPOCAMPUS;

EID: 0031965296     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01345273     Document Type: Conference Paper

References (21)

1. Alberati-Giani D, Ricciardi-Castagnoli P, Köhler C, Cesura AM (1996) Regulation of the kynurenine metabolic pathway by interferon-γ in murine cloned macrophages and microglial cells. J Neurochem 66: 996-1004
2. Blight AR, Cohen TI, Saito K, Heyes MP (1995) Quinolinic acid accumulation and functional deficits following experimental spinal cord injury. Brain 118: 735-752
3. Foster AC, White RJ, Schwarcz R (1986) Synthesis of quinolinic acid by 3-hydroxyan-thranilic oxygenase in rat brain tissue in vitro. J Neurochem 47: 23-30
4. Giulian D, Vaca K, Corpuz M (1993) Brain glia release factors with opposing actions upon neuronal survival. J Neurosci 13: 29-37
5. Heyes MP, Quearry BJ, Markey SP (1989) Systemic endotoxin increases L-tryptophan, 5-hydroxyindoleacetic acid, 3-hydroxykynurenine and quinolinic acid content of mouse cerebral cortex. Brain Res 491: 173-179
6. Heyes MP, Saito K, Crowley J, Davies LE, Demitrak MA, Der M, Dilling L, Kruesi MPJ, Lackner A, Larsen SA, Lee K, Leonard H, Markey SP, Martin A, Milstein S, Mouradian MM, Pranzatelli MR, Querry BJ, Salazar A, Smith M, Straus SE, Sutherland T, Swedo S, Tourtellotte WW (1992) Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 115: 1249-1273
7. Heyes MP, Saito K, Major EO, Milstein S, Markey SP, Vickers JH (1993) A mechanism of quinolinic acid formation by brain in inflammatory neurological disease: attenuation of synthesis from L-tryptophan by 6-chloro-tryptophan and 4-chloro-3-hydroxyanthranilate. Brain 116: 1425-1450
8. Lapin IP (1978) Stimulant and convulsant effects of kynurenines injected into brain ventricles in mice. J Neural Transm 42: 37-43
9. Luthman J, Vänerman E, Fredriksson G, Fornstedt-Wallin B (1996) Regulation of quinolinic acid in the normal rat brain by kynurenine pathway precursors. In: Allegri Filippini G, Costa CVL, Bertazzo A (eds) Recent advances in tryptophan research. Plenum Press, New York, pp 229-239
10. Malherbe P, Köhler C, Da Prada M, Lang G, Kiefer V, Schwarcz R, Lahm H-W, Cesura AM (1994) Molecular cloning and functional expression of human 3-hydroxyanthranilic-acid dioxygenase. J Biol Chem 269: 13792-13797
11. Nakagawa Y, Asai H, Kitoh J, Mori H, Nakano K (1995) Increases in the level of mRNA for 3-hydroxyanthranilate 3,4-dioxygenase in brain of epilepsy-prone IL mice. Biosci Biotech Biochem 59: 2191-2192
12. Rios C, Santamaria A (1991) Quinolinic acid is a potent lipid peroxidant in rat brain homogenate. Neurochem Res 16: 1139-1143
13. Rothwell NJ (1991) Functions and mechanisms of interleukin-1 in brain. TIPS 12: 430-435
14. Saito K, Markey SP, Heyes MP (1994) 6-Chloro-D,L-tryptophan, 4-chloro-3-hydroxyanthranilate and dexamethasone attenuate quinolinic acid accumulation in brain and blood following systemic immune activation. Neurosci Lett 178: 211-215
15. Saito K, Nowak TS, Markey SP, Heyes MP (1993) Mechanism of delayed increases in kynurenine pathway metabolism in damages brain regions following transient cerebral ischemia. J Neurochem 60: 180-189
16. Schurr A, Rigor BM (1993) Quinolinate potentiates neurotoxicity of excitatory amino acids in hypoxic neuronal tissue in vitro. Brain Res 617: 76-80
17. Schwarcz R, Whetsell WO, Mangano REM (1983) Quinolinic acid: an endogenous metabolite can produce axon sparing lesions in rat brain. Science 219: 316-318
18. Stone TW (1993) Neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev 45: 310-379
19. Studer L, Spenger C, Luthman J, Seiler RW (1994) NGF increases neuritic complexity of cholinergic interneurons in organotypic cultures of neonatal rat striatum. J Comp Neurol 340: 281-296
20. Todd WP, Carpenter BK, Schwarcz R (1989) Preparation of 4-halo-hydroxyanthralinates and demonstration of their inhibition 3-hydroxyanthralinate oxygenase activity in rat and human brain tissue. Prep Biochem 19: 155-165
21. Whetsell WO, Schwarcz R (1989) Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system. Neurosci Lett 97: 271-275